BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lacticaseibacillus rhamnosus {l. rhamnosus} - unclassified Escherichia |
👶
Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1081778 Pub: 2022 Epub: 2023 Jan 5 Authors Han M , Liao W , Dong Y , Bai C , Gai Z , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - unclassified Escherichia |
👶
Elucidation of Anti-Hypertensive Mechanism by a Novel Lactobacillus rhamnosus AC1 Fermented Soymilk in the Deoxycorticosterone Acetate-Salt Hypertensive Rats. Nutrients (Nutrients ) Vol: 14 Issue 15 Pages: Pub: 2022 Aug 2 Epub: 2022 Aug 2 Authors Wu H , Jiang L , Shum TF , Chiou J , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - unclassified Escherichia |
👶
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
